Seven patients have achieved objective stable disease, including tumor reduction ... and are undergoing DLT assessment. VIP943 PK data shows very little free payload in circulation, consistent ...
(2012) Constipation was the DLT. Peripheral neuropathy ... activity and a good toxicity profile in patients with ovarian cancer and adenocarcinoma of the lung. In a Phase II trial, vintafolide ...
Vietnam Investment Review on MSN14h
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian CancerInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback